XML 37 R27.htm IDEA: XBRL DOCUMENT v3.10.0.1
COMMON STOCK AND STOCK-BASED COMPENSATION PLANS (Tables)
9 Months Ended
Sep. 30, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Summary of Stock Option Activity

A summary of the Company’s stock option and SARs activities and related information for the nine months ended September 30, 2018, are as follows:

 

     Number of
options
and SAR
units (1)
     Weighted
average
exercise
price
     Weighted
average
remaining
contractual
term
     Aggregate
intrinsic-
value
 

Outstanding as of December 31, 2017

     729,017      $  19.77        5.2      $  19,229  

Granted

     —          —          

Exercised

     (19,474      16.22        

Forfeited or expired

     (2,128      20.50        
  

 

 

          

Outstanding as of September 30, 2018 (2)

     707,415      $ 19.87        4.5      $ 6,447  
  

 

 

    

 

 

    

 

 

    

 

 

 

Exercisable as of September 30, 2018 (3)

     610,731      $ 18.96        4.2      $ 6,089  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

  (1)

The SAR units are convertible for a maximum number of shares of the Company’s common stock equal to 75% of the SAR units subject to the grant.

 

  (2)

Due to the ceiling imposed on the SAR grants, the outstanding amount equals a maximum of 645,874 shares of the Company’s common stock issuable upon exercise.

 

  (3)

Due to the ceiling imposed on the SAR grants, the exercisable amount equals a maximum of 553,861 shares of the Company’s common stock issuable upon exercise.

Summary of Restricted Stock Units Activity

A summary of the Company’s RSU activities and related information for the nine months ended September 30, 2018, are as follows:

 

     Number of
RSUs
     Weighted Average
Grant-Date
Fair Value
 

Unvested as of December 31, 2017

     560,616      $ 29.31  

Granted

     304,496        34.83  

Vested

     (268,052      27.73  

Forfeited or expired

     (30,865      35.46  
  

 

 

    

 

 

 

Unvested as of September 30, 2018

     566,195      $  32.70  
  

 

 

    

 

 

 
Equity-Based Compensation Expense Included in Interim Condensed Consolidated Statements of Income

The following table shows the total equity-based compensation expense included in the interim condensed consolidated statements of income:

 

     Nine months ended
September 30,
     Three months ended
September 30,
 
     2018
(unaudited)
     2017
(unaudited)
     2018
(unaudited)
     2017
(unaudited)
 

Cost of revenue

   $ 480      $ 330      $ 155      $ 125  

Research and development, net

     3,874        2,834        1,246        991  

Sales and marketing

     1,246        1,040        369        381  

General and administrative

     2,483        2,142        697        722  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total equity-based compensation expense

   $  8,083      $  6,346      $  2,467      $  2,219  
  

 

 

    

 

 

    

 

 

    

 

 

 
Assumptions Used to Estimate Fair Value of Employee Stock Purchase Plan

The fair value for rights to purchase shares of common stock under the Company’s employee stock purchase plan was estimated on the date of grant using the following assumptions:

 

     Nine months ended
September 30,
    Three months ended
September 30,
 
     2018
(unaudited)
    2017
(unaudited)
    2018
(unaudited)
    2017
(unaudited)
 

Expected dividend yield

     0     0     0     0

Expected volatility

     35%-42     28%-46     38     28%-43

Risk-free interest rate

     0.7%-2.2     0.5%-1.1     2.2     0.6%-1.1

Contractual term of up to

     24 months       24 months       24 months       24 months